Q301--New Long-Term Renal/Kidney FY25 08/01/2025 - 07/31/2030 Donor-derived cell-free DNA tests.
ID: 36C26025Q0439Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF260-NETWORK CONTRACT OFFICE 20 (36C260)VANCOUVER, WA, 98661, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/2b62a7bb5eda4bef88e0826cf352deb2/view
Timeline
  1. 1
    Posted Apr 4, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 4, 2025, 12:00 AM UTC
  3. 3
    Due Apr 19, 2025, 12:00 AM UTC
Description

The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking qualified contractors to provide donor-derived cell-free DNA testing services for kidney transplant surveillance at the VA Portland Healthcare System. The selected Reference Laboratory will be responsible for specimen acquisition, testing, and timely reporting of results, ensuring compliance with federal regulations and maintaining high standards of patient care. This non-invasive testing is crucial for monitoring kidney transplant rejections, thereby enhancing healthcare quality for veterans. Interested parties must submit their capabilities statements to Contract Specialist Hector D. Gonzalez at hector.gonzalez1@va.gov, with the contract period expected to run from August 1, 2025, to July 31, 2030.

Point(s) of Contact
Hector D GonzalezContract Specialist
hector.gonzalez1@va.gov
Files
Title
Posted
36C26025Q0439_1.docx
Apr 3, 2025, 11:07 PM UTC
The VA Portland Healthcare System is issuing a Sources Sought Notice for a contract concerning donor-derived cell-free DNA (dd-cfDNA) tests for kidney transplant surveillance. Scheduled from August 1, 2025, to July 31, 2030, the contract will support the Pathology and Laboratory Medicine Service. The dd-cfDNA tests are non-invasive, helping monitor for kidney transplant rejection, thus reducing the need for invasive biopsies and expediting result turnaround times. The contract will ensure necessary services for specimen acquisition, testing, interpretation, and customer support, enabling healthcare providers to deliver high-quality care to veterans. This initiative underlines the VA's commitment to improving transplant monitoring and enhancing healthcare outcomes for kidney transplant recipients in the Western Region.
36C26025Q0439.docx
Apr 4, 2025, 3:04 PM UTC
The Department of Veterans Affairs' Network Contracting Office 20 is conducting market research to find qualified contractors to supply medical-grade liquid bulk oxygen and ancillary services for VA medical facilities in the Portland area. Interested parties must submit a capabilities statement detailing their business information, capabilities, and compliance with the Statement of Work. The Portland VA Healthcare System specifically needs a Reference Laboratory capable of providing kidney transplant surveillance through non-invasive donor-derived cell-free DNA testing. This lab must operate under rigorous standards, ensuring timely specimen processing and results, mobile phlebotomy services, and compliance with federal regulations. The laboratory will be responsible for high-quality services, including specimen acquisition, testing, and reporting. Key requirements include maintaining turn-around times and managing sensitive patient information securely. Overall, the document outlines the scope of services needed, qualifications for interested parties, and the overall intention of securing reliable laboratory services to enhance healthcare for veterans.
Similar Opportunities
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
Q301--Reference Laboratory Testing Services - El Paso VA
Buyer not available
The Department of Veterans Affairs is seeking sources for Reference Laboratory Testing Services for the El Paso Veterans Health Care System (EPVHCS). The procurement aims to identify vendors capable of providing laboratory tests that cannot be performed on-site due to capacity limitations, ensuring compliance with standards set by the Centers for Medicare & Medicaid Services (CMS) and the Clinical Laboratory Improvement Amendments (CLIA). These laboratory services are critical for diagnosing, treating, and monitoring health conditions among veterans, reflecting the VA's commitment to high-quality healthcare. Interested vendors must submit their responses, including company information and a capability statement, by April 28, 2025, and may direct inquiries to Contract Specialist Kathryn Prose at kathryn.prose@va.gov by April 10, 2025.
6640--LAB - INFECTIOUS DISEASE RETROVIRUS TRANSPLANT AND METABOLIC TESTING
Buyer not available
The Department of Veterans Affairs intends to award a sole-source firm fixed-price contract to Abbott Laboratories, Inc. for consumables and supplies necessary for in-house testing at the James J. Peters Veterans Affairs Medical Center and New York Harbor Healthcare System. The procurement aims to secure two automated single platform immunoassay analyzers to conduct a comprehensive range of immunosuppressant tests, including HIV, Tacrolimus, and Syrolimus, while achieving a minimum 95% confidence interval for assay accuracy. This initiative is critical for enhancing testing capabilities amidst staffing challenges and is part of the VA's strategic approach to optimize healthcare delivery. Interested parties may submit responses by April 17, 2025, although participation is voluntary and will not be compensated; for further inquiries, contact Contracting Officer Paul Speedling at Paul.Speedling@va.gov or 914-737-4400 x202107.
Pathology Testing
Buyer not available
The Defense Health Agency (DHA) is conducting a Sources Sought announcement to identify potential vendors for pathology testing services to support the Alexander T. Augusta Military Medical Center (ATAMMC) in Fort Belvoir, Virginia. The procurement aims to secure a vendor capable of collecting surgical case blocks for processing, embedding, and slide preparation, with a strict turnaround time of 24-48 hours and an annual volume of approximately 5,000 cases. This testing service is crucial for accurate clinical diagnostics, as it involves the use of various Immunohistochemistry (IHC) markers, which are essential for pathology evaluations and research within government-funded healthcare initiatives. Interested parties must submit their capabilities statements by 9:00 AM EST on Tuesday, January 22, 2025, and can direct inquiries to Contract Specialist Pamela Renteria at pamela.i.renteria.civ@health.mil.
B533--Facility Water Testing Services (VA-25-00057498)
Buyer not available
The Department of Veterans Affairs (VA) is seeking qualified contractors to provide facility water quality testing services for various VA medical facilities as part of the Western States Network Consortium (WSNC). The procurement aims to ensure comprehensive water sampling and testing across multiple water sources, focusing on parameters such as legionella, pH, and bacterial levels, while adhering to high standards for laboratory testing and regulatory compliance. This initiative is crucial for maintaining water safety and health standards within facilities that serve patients and staff. Interested parties must submit their capabilities statements, including proof of accreditation and specific testing capabilities, to Wendy Duval at wendy.duval@va.gov by 3:00 PM PST on April 17, 2023. This is a sources sought notice only, and no solicitation is currently available.
6550--BD MGIT Mycobacterium
Buyer not available
The Department of Veterans Affairs (VA) intends to establish a Blanket Purchase Agreement (BPA) for the BD Bactec MGIT 960 Mycobacterial Detections System, which is crucial for automated Tuberculosis testing across various VISN 1 facilities. This procurement encompasses a five-year agreement that includes the provision of necessary instrumentation, supplies, reagents, maintenance services, and training for VA personnel, ensuring uninterrupted laboratory operations and compliance with regulatory standards. The selected contractor will be responsible for delivering FDA-approved equipment capable of efficiently processing Mycobacterium tuberculosis samples while maintaining stringent security and operational standards. Interested vendors must submit their responses to Contract Specialist Sarah Otis at Sarah.Otis@va.gov by April 25, 2025, as this is a sole source procurement with no solicitation currently available.
6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
Buyer not available
The Department of Veterans Affairs intends to award a sole-source contract to Cepheid for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to meet the government's requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time. Interested parties should submit their technical packages to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov, noting that the government will not compensate for the information provided.
Q301--Request For Information (RFI) Reference Lab Testing Community Based Outpatient Clinic (CBOC) for Billings, Miles City VA Clinic and Community Living Center
Buyer not available
The Department of Veterans Affairs (VA) is seeking information from businesses capable of providing Reference Laboratory Testing Services for its Community Based Outpatient Clinics (CBOC) located in Billings and Miles City, Montana. The services required include testing of venous and arterial blood samples and urine samples from veteran patients, as well as the collection and testing of laboratory samples for routine and emergent care decisions. This opportunity is classified under NAICS code 541380, with a business size standard of $10 million, and serves as a preliminary market research effort rather than a solicitation for quotations. Interested parties must submit a capability statement detailing their qualifications and business size by 9 AM Mountain Time on April 18, 2025, to Contract Specialist Ernest Appiah at Ernest.Appiah@va.gov.
Neutrophil antibody testing and various blood products for the Department of Transfusion Medicine
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole-source contract to the American National Red Cross for neutrophil antibody testing and various blood products for the Department of Transfusion Medicine. This procurement aims to address the critical need for specialized blood products and testing services essential for patients with conditions such as sickle cell disease and Severe Aplastic Anemia, who require phenotype-matched blood and HLA-matched platelets. The anticipated period of performance for this indefinite delivery/indefinite quantity (IDIQ) task order is from May 1, 2025, through April 30, 2026, with a total estimated value not exceeding $250,000. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by April 21, 2025, at 6:30 AM EST.